Position in CGEN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,017,850
+$539,586 QoQ
Shares Held
1,877,500
+15.0% QoQ
Ownership
1.98%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2
of 82 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,606,887 across 312 Biotechnology names. CGEN ranks #92 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in CGEN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,017,850 | 1,877,500 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,478,264 | 1,632,988 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,229,057 | 1,456,900 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,065,842 | 1,405,335 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,362,238 | 1,327,100 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,037,097 | 1,395,272 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,954,116 | 1,277,200 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,329,651 | 1,287,100 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,165,352 | 1,288,900 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,346,260 | 1,297,000 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,219,778 | 1,121,100 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,017,699 | 1,094,300 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,183,776 | 1,038,400 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $656,670 | 938,100 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $917,111 | 1,273,766 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,565,947 | 2,372,648 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,405,133 | 1,300,072 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,599,876 | 807,415 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $988,570 | 229,900 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,013,631 | 672,300 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,538,716 | 789,700 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,477,369 | 404,816 | Shares | Sole | 2021-05-13 | |
| 2020-06-30 | $483,644 | 32,200 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,375,174 | 464,900 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||